Health
Pfizer to Seek FDA Approval for COVID-19 Vaccine After Election – Latin Post
Pfizer said their company will not ask for Food and Drug Administration (FDA) approval for their COVID-19 vaccine candidate until after the election.
Pfizer said their company will not ask for Food and Drug Administration (FDA) approval for their COVID-19 vaccine candidate until after the election.
As Pfizer CEO Albert Bourla said in an open letter, their COVID-19 vaccine cannot request for emergency FDA approval before the third week of November.
The timeline is only based on Pfizer’s best estimates and does not account for delays on the COVID-19 vaccine, said an Associated Press report.
Bourla said that if they do ask for FDA approval, t…
-
General11 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News17 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General23 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
General12 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery